Renovaro Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Renovaro Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Renovaro Biosciences Inc
Rating: 0.78308325
Author: Trendlyne DVM scores

about

Lunai Bioworks Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

0.21 0.00 (0.00%)

New 52W Low today

524.5K

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Renovaro Biosciences Inc is on 09 Sep 2025 for the purpose of Lunai Bioworks Inc Annual General Meeting for 2024 See details

Not Eligible

Expensive Valuation

14.8 / 100

Technically Bearish

16.5 / 100

No estimates available

Renovaro Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Renovaro Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Lunai Bioworks Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

New 52W Low today

SWOT Analysis

Renovaro Biosciences Inc Live Price Chart